Atlas Trials

Selinexor Plus Combination Chemotherapy in Treating Patients With Advanced B Cell Non-Hodgkin Lymphoma

Clinical trial NCT03147885 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03147885
Sponsor
Barbara Ann Karmanos Cancer Institute
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Diffuse Large B-Cell LymphomaRecurrent B-Cell Non-Hodgkin LymphomaRecurrent Extranodal Marginal Zone LymphomaRecurrent Follicular LymphomaRecurrent Indolent Adult Non-Hodgkin LymphomaRecurrent Mantle Cell LymphomaRecurrent Marginal Zone LymphomaRecurrent Waldenstrom MacroglobulinemiaRefractory B-Cell Non-Hodgkin LymphomaRefractory Extranodal Marginal Zone LymphomaRefractory Follicular LymphomaRefractory Mantle Cell Lymphoma
Start date
2017-06-20
Primary completion
2027-12-01
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.